Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL16962091

NC(=O)c1c(NC(=O)Nc2ccc(Cl)cc2)sc2c1CCN(CCC(=O)O)C2.O=C(O)C(F)(F)F

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 10/20 0.70
KDM4E B2RXH2 2/20 0.59
MAPT P10636 2/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
USP2 O75604 1/20 0.59
LMNA P02545 1/20 0.59
HTT P42858 1/20 0.59
ATM Q13315 1/20 0.59
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
MAPK1 P28482 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16962536 0.95 KCNH2 (0.77) KCNH2KDM4EMAPTMEN1KMT2A
Trifluoroacetic Acid SCHEMBL16960573 0.91 KCNH2 (0.69) KCNH2KDM4EMAPTMEN1KMT2A
Trifluoroacetic Acid SCHEMBL17006320 0.90 KCNH2 (0.68) KCNH2KDM4EMAPTMEN1KMT2A
SCHEMBL17006328 0.89 KCNH2 (0.75) KCNH2KDM4EMAPTMEN1KMT2A
Trifluoroacetic Acid SCHEMBL17006414 0.89 KCNH2 (0.69) KCNH2KDM4EMAPTMEN1KMT2A
SCHEMBL17006337 0.89 KCNH2 (0.73) KCNH2KDM4EMAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL16962593 0.89 KCNH2 (0.75) KCNH2KDM4EMAPTMEN1KMT2A
SCHEMBL16962388 0.88 KCNH2 (0.79) KCNH2KDM4EMAPTMEN1KMT2A
SCHEMBL16962753 0.88 KCNH2 (0.72) KCNH2KDM4EMAPTMEN1KMT2A
SCHEMBL16962093 0.87 KCNH2 (0.67) KCNH2KDM4EMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9902738-B2 Compounds and methods for preventing, treating and/or protecting against sensory hair cell death UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2018-02-27 US disclosed
EP-2900674-B1 COMPOUNDS AND METHODS FOR PREVENTING, TREATING AND/OR PROTECTING AGAINST SENSORY HAIR CELL DEATH UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2017-05-31 EP disclosed
US-20160326186-A1 COMPOUNDS AND METHODS FOR PREVENTING, TREATING AND/OR PROTECTING AGAINST SENSORY HAIR CELL DEATH FRED HUTCHINSON CANCER CENTER 2016-11-10 US disclosed
US-9416141-B2 Compounds and methods for preventing, treating and/or protecting against sensory hair cell death UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2016-08-16 US disclosed
US-20150232476-A1 COMPOUNDS AND METHODS FOR PREVENTING, TREATING AND/OR PROTECTING AGAINST SENSORY HAIR CELL DEATH UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION 2015-08-20 US disclosed
EP-2900674-A1 COMPOUNDS AND METHODS FOR PREVENTING, TREATING AND/OR PROTECTING AGAINST SENSORY HAIR CELL DEATH University of Washington through its Center for Commercialization (US) 2015-08-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160326186-A1 COMPOUNDS AND METHODS FOR PREVENTING, TREATING AND/OR PROTECTING AGAINST SENSORY HAIR CELL DEATH BAX, CASP3, BCL2 KCNH2 2265/4885KDM4E 4348/4885MAPT 2252/4885
US-20150232476-A1 COMPOUNDS AND METHODS FOR PREVENTING, TREATING AND/OR PROTECTING AGAINST SENSORY HAIR CELL DEATH BAX, CASP3, BCL2 KCNH2 2265/4885KDM4E 4348/4885MAPT 2252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.